🇺🇸 FDA
Patent

US 11117888

Irreversible inhibitors of pyruvate kinase M2 and the use thereof

granted A61PA61P35/00

Quick answer

US patent 11117888 (Irreversible inhibitors of pyruvate kinase M2 and the use thereof) held by China Medical University expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00